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Introduction
The dogma of cancer biology is that tumours arise in a
multistep fashion, and colon cancer has been the para-
digm of this type of model. It is no surprise that the same
model has been adopted in other cancer types, and breast
cancer is no exception. Invasive breast cancer is believed
to arise via a series of intermediate lesions, which are cur-
rently classified as hyperplasias with and without atypia,
and in situ carcinomas.
The multistep model has also formed the basis for the
screening programmes instituted for cervical and breast
cancer. If tumours arise via intermediate steps and it is
possible to identify one or more of these steps, it becomes
possible to treat the patient before the tumour has had a
chance to metastasise.
Whether the screening programme has reduced the mor-
tality from breast cancer is a controversial issue. The con-
sensus view seems to be that it has had an impact on
mortality, although the level of reduction is hotly debated.
Whatever prejudices one holds, the fact remains that with
the introduction of the screening programme there has
been an increase in the detection of pre-invasive breast
disease, and this has highlighted deficiencies in the classi-
fication systems and the lack of knowledge regarding the
natural history of the lesions. This lack of knowledge has
led to significant problems in diagnosis and management
of patients with proliferative breast disease, so that
patients are offered diverse treatment options ranging
from ‘nothing’ to mastectomy.
The articles in the present thematic review series were
conceived to highlight the problems faced by doctors and
scientists dealing with pre-invasive breast disease, and to
throw light on the evolving classification systems and mol-
ecular techniques that are likely to change the way we
approach patients with these disorders.
The series will be published in two parts, the first half in
the present issue of Breast Cancer Research and the rest
of the papers in the following issue.
Andy Evans kicks off by describing the current challenges
in the radiological diagnosis of pre-invasive lesions [1].
This is followed by a series of papers dealing with the
pathological classification. Sarah Pinder and Ian Ellis
discuss ductal carcinoma in situ and atypical ductal hyper-
plasia [2], and Peter Simpson and colleagues describe
the current status with lobular carcinoma in situ [3].
Recently, as a direct result of identifying calcification on
mammography, pathologists have been encountering a
range of proliferations, which have been described by an
array of names including columnar cell lesions/flat epithe-
lial atypia. Stuart Schnitt has summarised the current clas-
sification and management issues relating to diagnosis of
these lesions on core biopsies [4]. Should the patient with
flat atypia on a core biopsy have a further excision? Marc
Van der Vijver and Hans Peterse finish off the first half of
the series with their own views and concerns regarding
the existing terminology for classification, and provide a
personal approach (which may not be shared by all) as to
how they deal with the problem in their own practice [5].
In the Breast Cancer Research issue to follow, Ashutosh
Nerurkar and Peter Osin discuss the new techniques of
core biopsy and ductal lavage in diagnosis [6], and Arnie
Purushotham describes the surgical approach to manage-
ment of patients with early disease [7]. The last two arti-
cles in the series deal with molecular techniques used to
study pre-invasive breast lesions. Jorge Reis Filho and
Sunil Lakhani review the current data on genomic alter-
ation in hyperplasias and in situ carcinomas [8], and
Stefanie Jeffrey and Jonathan Pollack discuss how the
new and emerging technologies such as microarrays will
impact the understanding of these pre-cancerous
proliferations [9].
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The series of articles in these reviews intends to educate
as well as to raise questions about our knowledge,
prompting doctors and scientists to come together to
meet the challenge. It is hoped that this will make a differ-
ence to the management of patients with pre-invasive
breast disease.
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